Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;45(3):372-8.
doi: 10.1007/s12031-011-9533-3. Epub 2011 May 10.

Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia

Affiliations

Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia

Jennifer L Whitwell et al. J Mol Neurosci. 2011 Nov.

Abstract

Pathology underlying behavioral variant frontotemporal dementia (bvFTD) is heterogeneous, with the most common pathologies being Pick's disease (PiD), corticobasal degeneration (CBD), and FTLD-TDP type 1. Clinical features are unhelpful in differentiating these pathologies. We aimed to determine whether imaging atrophy patterns differ across these pathologies in bvFTD subjects. We identified 15 bvFTD subjects that had volumetric MRI during life and autopsy: five with PiD, five CBD, and five FTLD-TDP type 1. Voxel-based morphometry was used to assess atrophy patterns in each bvFTD group compared to 20 age- and gender-matched controls. All three pathological groups showed gray matter loss in frontal lobes, although specific patterns of atrophy differed across groups: PiD showed widespread loss in frontal lobes with additional involvement of anterior temporal lobes; CBD showed subtle patterns of loss involving posterior lateral and medial superior frontal lobe; and FTLD-TDP type 1 showed widespread loss in frontal, temporal, and parietal lobes. Greater parietal loss was observed in FTLD-TDP type 1 compared to both other groups, and greater anterior temporal and medial frontal loss was observed in PiD compared to CBD. Imaging patterns of atrophy in bvFTD vary according to pathological diagnosis and may therefore be helpful in predicting these pathologies in bvFTD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patterns of grey matter loss observed in bvFTD subjects with PiD, CBD or FTLD-TDP type 1 pathology compared to controls. Results are shown uncorrected for multiple comparisons at p<0.001 on medial and lateral three dimensional renderings of the brain.
Figure 2
Figure 2
Regions of grey matter loss that were different between the bvFTD subjects with PiD, CBD or FTLD-TDP type 1 pathology. The top panel shows regions of greater loss in PiD compared to CBD; the middle panel shows regions of greater loss in FTLD-TDP type 1 compared to CBD; and the bottom panel shows regions of greater loss in FTLD-TDP type 1 compared to PiD. Results are shown uncorrected for multiple comparisons at p<0.001 on medial and lateral three dimensional renderings of the brain.

Similar articles

Cited by

References

    1. Ashburner J, Friston KJ. Voxel-based morphometry--the methods. NeuroImage. 2000;11:805–821. - PubMed
    1. Ashburner J, Friston KJ. Unified segmentation. NeuroImage. 2005;26:839–851. - PubMed
    1. Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. Journal of neuropathology and experimental neurology. 2001;60:328–341. - PubMed
    1. Boccardi M, Sabattoli F, Laakso MP, et al. Frontotemporal dementia as a neural system disease. Neurobiology of aging. 2005;26:37–44. - PubMed
    1. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5–22. - PMC - PubMed

Publication types